Physician profile
Mark A Farag
NPI 1346565991
$7,615.50
in general payments reported to CMS, 2019-2025
15 companies · $374 in 2025
The $374 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,445 · 2020: $809 · 2021: $820 · 2022: $780 · 2023: $713 · 2024: $674 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,761.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,088.91 | 2019-2025 | Eterna, Proclaim |
| Electronic Waveform Lab, INC. | $2,346.89 | 2019-2024 | |
| Bioventus LLC | $1,107.06 | 2019 | |
| Si-Bone, INC. | $207.12 | 2019-2024 | |
| Mml US, INC. | $182.16 | 2021 | |
| Painteq LLC | $178.18 | 2023-2025 | Painteq |
| Vertiflex, INC. | $149.63 | 2019 | |
| Nalu Medical, INC. | $92.37 | 2024 | Nalu Neurostimulation System |
| Abbvie INC. | $72.55 | 2021-2025 | |
| Medtronic USA, INC. | $70.70 | 2019 | |
| Medtronic, INC. | $43.47 | 2022 | |
| Allergan, INC. | $31.73 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $16.35 | 2022 | |
| Collegium Pharmaceutical, INC. | $14.88 | 2019 | |
| Masimo Corporation | $13.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Farag listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.